| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 10, 2004
Accepted on November 1, 2004
From the Institute of Pharmacology (C.J.W.) and the First Department of Medicine (M.L.K.), University Hospital Schleswig-Holstein, Campus Kiel; the Institute of Anatomy (T.P.), University of Kiel; the Center for Cardiovascular Research/Institute of Pharmacology and Toxicology (H.K., M.M., H.F.-K., J.S., T.U.), Charité-University Medicine Berlin; and the Institute for Arteriosclerosis Research at the University of Muenster (M.S.), Germany.
* To whom correspondence should be addressed. E-mail: thomas.unger{at}charite.de.
Objective--Synthesis and maturation of G protein-coupled receptors are complex events that require an intricate combination of processes including protein folding, posttranslational modifications, and transport through distinct cellular compartments. Little is known concerning the regulation of G protein-coupled receptor transport from the endoplasmic reticulum to the cell surface.
Methods and Results--Here we show that the cytoplasmatic carboxy-terminal of the angiotensin AT2 receptor (AT2R) acts independently as an endoplasmic reticulum-export signal. Using a yeast two-hybrid system, we identified a Golgi membrane-associated protein termed ATBP50 (for AT2R binding protein of 50 kDa) that binds to this motif. We also cloned ATBP60 and ATBP135 encoded by the same gene as ATBP50 that mapped to chromosomes 8p21.3. Downregulation of ATBP50 using siRNA leads to retention of AT2R in inner compartments, reduced cell surface expression, and decreased antiproliferative effects of the receptor.
Conclusion--Our results indicate that ATBP50 regulates the transport of the AT2R to cell membrane by binding to a specific signal within its cytoplasmic carboxy-terminal and thereby enabling the antiproliferative effects of the receptor.
Related Article:
This article has been cited by other articles:
![]() |
M. Mogi, M. Iwai, and M. Horiuchi Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2532 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, J. L. Bermejo, K. Hemminki, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle-Bahat, P. Bugert, R. K. Schmutzler, C. R. Bartram, et al. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk Carcinogenesis, July 1, 2007; 28(7): 1442 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1 Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.J. Landon and T. Inagami Beyond the G Protein: The Saga of the Type 2 Angiotensin II Receptor Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 15 - 16. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |